Inhibitory effects of simultaneously applied lafutidine with NSAIDs on formation of gastric mucosal lesions in rats

Shizuko Tsuchiya, Tomonori Nakamura, Shingo Yano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: Lafutidine is a novel H2 receptor antagonist with gastric antisecretory and gastro-protective activities as well as stimulatory activity on vanilloid receptor. We examined the influence of lafutidine, teprenone and misoprostol on acute gastric mucosal lesions induced by NSAIDs (diclofenac and aspirin) in rats to compare their efficiency in the case of simultaneous application with NSAIDs. Methods: Rats, fasted for 24h, were given orally lafutidine (3,10, 30mg/ kg), teprenone (10, 30, 100mg/kg) or misoprostol (0.3mg/kg) with aspirin (300mg/kg) or diclofenac (40mg/kg). The mucosal lesion length (mm) was measured. Results: Aspirin and diclofenac caused acute gastric mucosal lesions in gastric corpus at 6h later. Lafutidine dose- dependently and significantly prevented the development of gastric lesions. Misoprostol also strongly inhibited the development of gastric lesions, while teprenone showed no protective effect. Conclusion: Simultaneous application of lafutidine or misoprostol, but not teprenone, with NSAIDs efficiently protected the gastric lesions.

Original languageEnglish
Pages (from-to)159-164
Number of pages6
JournalJapanese Pharmacology and Therapeutics
Volume35
Issue number2
Publication statusPublished - 2007
Externally publishedYes

Fingerprint

geranylgeranylacetone
Non-Steroidal Anti-Inflammatory Agents
Stomach
Misoprostol
Diclofenac
Aspirin
TRPV Cation Channels
Histamine H2 Receptors
lafutidine

Keywords

  • Acute gastric mucosal lesions
  • Lafutidine
  • Nonsteroidal anti-inflammatory drugs (NSAIDs)

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Inhibitory effects of simultaneously applied lafutidine with NSAIDs on formation of gastric mucosal lesions in rats. / Tsuchiya, Shizuko; Nakamura, Tomonori; Yano, Shingo.

In: Japanese Pharmacology and Therapeutics, Vol. 35, No. 2, 2007, p. 159-164.

Research output: Contribution to journalArticle

@article{945c44100db449ca8e9d33911e6721d5,
title = "Inhibitory effects of simultaneously applied lafutidine with NSAIDs on formation of gastric mucosal lesions in rats",
abstract = "Objective: Lafutidine is a novel H2 receptor antagonist with gastric antisecretory and gastro-protective activities as well as stimulatory activity on vanilloid receptor. We examined the influence of lafutidine, teprenone and misoprostol on acute gastric mucosal lesions induced by NSAIDs (diclofenac and aspirin) in rats to compare their efficiency in the case of simultaneous application with NSAIDs. Methods: Rats, fasted for 24h, were given orally lafutidine (3,10, 30mg/ kg), teprenone (10, 30, 100mg/kg) or misoprostol (0.3mg/kg) with aspirin (300mg/kg) or diclofenac (40mg/kg). The mucosal lesion length (mm) was measured. Results: Aspirin and diclofenac caused acute gastric mucosal lesions in gastric corpus at 6h later. Lafutidine dose- dependently and significantly prevented the development of gastric lesions. Misoprostol also strongly inhibited the development of gastric lesions, while teprenone showed no protective effect. Conclusion: Simultaneous application of lafutidine or misoprostol, but not teprenone, with NSAIDs efficiently protected the gastric lesions.",
keywords = "Acute gastric mucosal lesions, Lafutidine, Nonsteroidal anti-inflammatory drugs (NSAIDs)",
author = "Shizuko Tsuchiya and Tomonori Nakamura and Shingo Yano",
year = "2007",
language = "English",
volume = "35",
pages = "159--164",
journal = "Japanese Pharmacology and Therapeutics",
issn = "0386-3603",
publisher = "Life Science Publishing Co. Ltd",
number = "2",

}

TY - JOUR

T1 - Inhibitory effects of simultaneously applied lafutidine with NSAIDs on formation of gastric mucosal lesions in rats

AU - Tsuchiya, Shizuko

AU - Nakamura, Tomonori

AU - Yano, Shingo

PY - 2007

Y1 - 2007

N2 - Objective: Lafutidine is a novel H2 receptor antagonist with gastric antisecretory and gastro-protective activities as well as stimulatory activity on vanilloid receptor. We examined the influence of lafutidine, teprenone and misoprostol on acute gastric mucosal lesions induced by NSAIDs (diclofenac and aspirin) in rats to compare their efficiency in the case of simultaneous application with NSAIDs. Methods: Rats, fasted for 24h, were given orally lafutidine (3,10, 30mg/ kg), teprenone (10, 30, 100mg/kg) or misoprostol (0.3mg/kg) with aspirin (300mg/kg) or diclofenac (40mg/kg). The mucosal lesion length (mm) was measured. Results: Aspirin and diclofenac caused acute gastric mucosal lesions in gastric corpus at 6h later. Lafutidine dose- dependently and significantly prevented the development of gastric lesions. Misoprostol also strongly inhibited the development of gastric lesions, while teprenone showed no protective effect. Conclusion: Simultaneous application of lafutidine or misoprostol, but not teprenone, with NSAIDs efficiently protected the gastric lesions.

AB - Objective: Lafutidine is a novel H2 receptor antagonist with gastric antisecretory and gastro-protective activities as well as stimulatory activity on vanilloid receptor. We examined the influence of lafutidine, teprenone and misoprostol on acute gastric mucosal lesions induced by NSAIDs (diclofenac and aspirin) in rats to compare their efficiency in the case of simultaneous application with NSAIDs. Methods: Rats, fasted for 24h, were given orally lafutidine (3,10, 30mg/ kg), teprenone (10, 30, 100mg/kg) or misoprostol (0.3mg/kg) with aspirin (300mg/kg) or diclofenac (40mg/kg). The mucosal lesion length (mm) was measured. Results: Aspirin and diclofenac caused acute gastric mucosal lesions in gastric corpus at 6h later. Lafutidine dose- dependently and significantly prevented the development of gastric lesions. Misoprostol also strongly inhibited the development of gastric lesions, while teprenone showed no protective effect. Conclusion: Simultaneous application of lafutidine or misoprostol, but not teprenone, with NSAIDs efficiently protected the gastric lesions.

KW - Acute gastric mucosal lesions

KW - Lafutidine

KW - Nonsteroidal anti-inflammatory drugs (NSAIDs)

UR - http://www.scopus.com/inward/record.url?scp=56249126495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56249126495&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:56249126495

VL - 35

SP - 159

EP - 164

JO - Japanese Pharmacology and Therapeutics

JF - Japanese Pharmacology and Therapeutics

SN - 0386-3603

IS - 2

ER -